Literature DB >> 18724009

Molecular effects of the tissue-nonspecific alkaline phosphatase gene polymorphism (787T > C) associated with bone mineral density.

Natsuko Sogabe1, Kimimitsu Oda, Hiroyuki Nakamura, Hideo Orimo, Hisashi Watanabe, Takayuki Hosoi, Masae Goseki-Sone.   

Abstract

Based on studies of hypophosphatasia, which is a systemic skeletal disorder resulting from tissuenonspecific alkaline phosphatase (TNSALP) deficiency, TNSALP was suggested to be indispensable for bone mineralization. Recently, we demonstrated that there was a significant difference in bone mineral density (BMD) among haplotypes, which was lowest among TNSALP (787T [Tyr-246Tyr]) homozygotes, highest among TNSALP (787T > C [Tyr246His]) homozygotes, and intermediate among heterozygotes. To analyze protein translated from the TNSALP gene 787T > C, we performed the biosynthesis of TNSALPs using TNSALP cDNA expression vectors. TNSALP (787T) and TNSALP (787T > C) were synthesized similarly as a high-mannose-type 66-kDa form, becoming an 80-kDa form. Expression of the human 787T > C TNSALP gene using the cultured mouse marrow stromal cell line ST2 demonstrated that the protein translated from 787T > C exhibited an ALP-specific activity similarly to that of 787T. Interestingly, the Km value for TNSALP in ST2 cells transfected with the 787T > C TNSALP gene was decreased significantly compared to that of cells carrying the 787T gene (P < 0.01). These results suggest that the significant difference in Km values between the proteins translated from 787T > C and 787T may contribute to regulatory effects on bone metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18724009     DOI: 10.2220/biomedres.29.213

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  13 in total

Review 1.  Genetic aspects of osteoporosis.

Authors:  Takayuki Hosoi
Journal:  J Bone Miner Metab       Date:  2010-08-10       Impact factor: 2.626

2.  Morphological cell typing of osteoid clones derived from human bone marrow.

Authors:  Olga Tsilenko; Vera Astachova; Vladislav Malanchuk; Francesco Carinci
Journal:  J Maxillofac Oral Surg       Date:  2009-08-11

Review 3.  Genetics of osteoporosis: accelerating pace in gene identification and validation.

Authors:  Wen-Feng Li; Shu-Xun Hou; Bin Yu; Meng-Meng Li; Claude Férec; Jian-Min Chen
Journal:  Hum Genet       Date:  2009-12-12       Impact factor: 4.132

4.  Rescue of severe infantile hypophosphatasia mice by AAV-mediated sustained expression of soluble alkaline phosphatase.

Authors:  Tae Matsumoto; Koichi Miyake; Seiko Yamamoto; Hideo Orimo; Noriko Miyake; Yuko Odagaki; Kumi Adachi; Osamu Iijima; Sonoko Narisawa; José Luis Millán; Yoshitaka Fukunaga; Takashi Shimada
Journal:  Hum Gene Ther       Date:  2011-06-08       Impact factor: 5.695

5.  Prolonged survival and phenotypic correction of Akp2(-/-) hypophosphatasia mice by lentiviral gene therapy.

Authors:  Seiko Yamamoto; Hideo Orimo; Tae Matsumoto; Osamu Iijima; Sonoko Narisawa; Takahide Maeda; José Luis Millán; Takashi Shimada
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

6.  Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector.

Authors:  Aki Nakamura-Takahashi; Koichi Miyake; Atsushi Watanabe; Yukihiko Hirai; Osamu Iijima; Noriko Miyake; Kumi Adachi; Yuko Nitahara-Kasahara; Hideaki Kinoshita; Taku Noguchi; Shinichi Abe; Sonoko Narisawa; Jose Luis Millán; Takashi Shimada; Takashi Okada
Journal:  Mol Ther Methods Clin Dev       Date:  2016-02-03       Impact factor: 6.698

7.  Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.

Authors:  Delphine Fauvert; Isabelle Brun-Heath; Anne-Sophie Lia-Baldini; Linda Bellazi; Agnès Taillandier; Jean-Louis Serre; Philippe de Mazancourt; Etienne Mornet
Journal:  BMC Med Genet       Date:  2009-06-06       Impact factor: 2.103

8.  Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model.

Authors:  Takashi Tani; Megumi Fujiwara; Hideo Orimo; Akira Shimizu; Sonoko Narisawa; Anthony B Pinkerton; José Luis Millán; Shuichi Tsuruoka
Journal:  J Pathol       Date:  2019-11-23       Impact factor: 7.996

Review 9.  The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis.

Authors:  Florence Wl Tsui; Hing Wo Tsui; Ali Akram; Nigil Haroon; Robert D Inman
Journal:  Appl Clin Genet       Date:  2014-05-22

10.  Prenatal enzyme replacement therapy for Akp2 -/- mice with lethal hypophosphatasia.

Authors:  Akihiro Hasegawa; Aki Nakamura-Takahashi; Masataka Kasahara; Nana Saso; Sonoko Narisawa; José Luis Millán; Osamu Samura; Haruhiko Sago; Aikou Okamoto; Akihiro Umezawa
Journal:  Regen Ther       Date:  2021-07-05       Impact factor: 3.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.